In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)

Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial procedural costs by $151/patient ($4,423 vs $4,574, p=0.005) and costs related to ischemic complications by $61/patient ($283 vs $344, p=0.002).

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2002, Vol.89 (1), p.61-64
Main Authors: Cohen, David J., O’Shea, J.Conor, Pacchiana, Cindy M., Levine, Glenn, Sarembock, Ian, Slater, James, Conn, Eric, Smith, Jack, Tcheng, James E.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Coronary vessels
Drug therapy
Hospital costs
Medical sciences
Pharmacology. Drug treatments
Stents
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413
cites cdi_FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413
container_end_page 64
container_issue 1
container_start_page 61
container_title The American journal of cardiology
container_volume 89
creator Cohen, David J.
O’Shea, J.Conor
Pacchiana, Cindy M.
Levine, Glenn
Sarembock, Ian
Slater, James
Conn, Eric
Smith, Jack
Tcheng, James E.
description Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial procedural costs by $151/patient ($4,423 vs $4,574, p=0.005) and costs related to ischemic complications by $61/patient ($283 vs $344, p=0.002).
doi_str_mv 10.1016/S0002-9149(01)02165-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_230368786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914901021658</els_id><sourcerecordid>99717538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413</originalsourceid><addsrcrecordid>eNqFkNFLHDEQxoNU8Gr9EwqhUNCHbTOb7G72qRSx7YGg6PU55JIJF1mTNckp_veNd2IffZoZ5vfNx3yEfAb2DRj0328ZY20zghhPGZyxFvqukQdkAXIYGxiBfyCLN-SIfMz5ro4AXb8gehmaTcyzL3qiJuaSaXS1STHo9ExzwVCov58nHYouPgb65MuG6mB3TdwWinPxzq_r1iI9LRukF7fXN8sVXSWvp7NP5NDpKePJaz0mf39drM7_NJdXv5fnPy8bw3tRGomttkw7K2B0pmNccNnJdb8WnRAgESSzppVuMOuBCTtiXbYj4GCdQC6AH5Mv-7tzig9bzEXdxW0K1VK1nPFeDrKvULeHTIo5J3RqTv6-fqqAqZcw1S5M9ZKUYqB2YSpZdV9fj-ts9OSSDsbn_2IuRD-2Q-V-7Dmsnz56TCobj8Gg9QlNUTb6d5z-AbDhiFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230368786</pqid></control><display><type>article</type><title>In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Cohen, David J. ; O’Shea, J.Conor ; Pacchiana, Cindy M. ; Levine, Glenn ; Sarembock, Ian ; Slater, James ; Conn, Eric ; Smith, Jack ; Tcheng, James E.</creator><creatorcontrib>Cohen, David J. ; O’Shea, J.Conor ; Pacchiana, Cindy M. ; Levine, Glenn ; Sarembock, Ian ; Slater, James ; Conn, Eric ; Smith, Jack ; Tcheng, James E.</creatorcontrib><description>Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial procedural costs by $151/patient ($4,423 vs $4,574, p=0.005) and costs related to ischemic complications by $61/patient ($283 vs $344, p=0.002).</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/S0002-9149(01)02165-8</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Coronary vessels ; Drug therapy ; Hospital costs ; Medical sciences ; Pharmacology. Drug treatments ; Stents ; Transplants &amp; implants</subject><ispartof>The American journal of cardiology, 2002, Vol.89 (1), p.61-64</ispartof><rights>2002 Excerpta Medica Inc.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jan 1, 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413</citedby><cites>FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13446927$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Cohen, David J.</creatorcontrib><creatorcontrib>O’Shea, J.Conor</creatorcontrib><creatorcontrib>Pacchiana, Cindy M.</creatorcontrib><creatorcontrib>Levine, Glenn</creatorcontrib><creatorcontrib>Sarembock, Ian</creatorcontrib><creatorcontrib>Slater, James</creatorcontrib><creatorcontrib>Conn, Eric</creatorcontrib><creatorcontrib>Smith, Jack</creatorcontrib><creatorcontrib>Tcheng, James E.</creatorcontrib><title>In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)</title><title>The American journal of cardiology</title><description>Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial procedural costs by $151/patient ($4,423 vs $4,574, p=0.005) and costs related to ischemic complications by $61/patient ($283 vs $344, p=0.002).</description><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Coronary vessels</subject><subject>Drug therapy</subject><subject>Hospital costs</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Stents</subject><subject>Transplants &amp; implants</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkNFLHDEQxoNU8Gr9EwqhUNCHbTOb7G72qRSx7YGg6PU55JIJF1mTNckp_veNd2IffZoZ5vfNx3yEfAb2DRj0328ZY20zghhPGZyxFvqukQdkAXIYGxiBfyCLN-SIfMz5ro4AXb8gehmaTcyzL3qiJuaSaXS1STHo9ExzwVCov58nHYouPgb65MuG6mB3TdwWinPxzq_r1iI9LRukF7fXN8sVXSWvp7NP5NDpKePJaz0mf39drM7_NJdXv5fnPy8bw3tRGomttkw7K2B0pmNccNnJdb8WnRAgESSzppVuMOuBCTtiXbYj4GCdQC6AH5Mv-7tzig9bzEXdxW0K1VK1nPFeDrKvULeHTIo5J3RqTv6-fqqAqZcw1S5M9ZKUYqB2YSpZdV9fj-ts9OSSDsbn_2IuRD-2Q-V-7Dmsnz56TCobj8Gg9QlNUTb6d5z-AbDhiFg</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Cohen, David J.</creator><creator>O’Shea, J.Conor</creator><creator>Pacchiana, Cindy M.</creator><creator>Levine, Glenn</creator><creator>Sarembock, Ian</creator><creator>Slater, James</creator><creator>Conn, Eric</creator><creator>Smith, Jack</creator><creator>Tcheng, James E.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>2002</creationdate><title>In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)</title><author>Cohen, David J. ; O’Shea, J.Conor ; Pacchiana, Cindy M. ; Levine, Glenn ; Sarembock, Ian ; Slater, James ; Conn, Eric ; Smith, Jack ; Tcheng, James E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Coronary vessels</topic><topic>Drug therapy</topic><topic>Hospital costs</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Stents</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cohen, David J.</creatorcontrib><creatorcontrib>O’Shea, J.Conor</creatorcontrib><creatorcontrib>Pacchiana, Cindy M.</creatorcontrib><creatorcontrib>Levine, Glenn</creatorcontrib><creatorcontrib>Sarembock, Ian</creatorcontrib><creatorcontrib>Slater, James</creatorcontrib><creatorcontrib>Conn, Eric</creatorcontrib><creatorcontrib>Smith, Jack</creatorcontrib><creatorcontrib>Tcheng, James E.</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cohen, David J.</au><au>O’Shea, J.Conor</au><au>Pacchiana, Cindy M.</au><au>Levine, Glenn</au><au>Sarembock, Ian</au><au>Slater, James</au><au>Conn, Eric</au><au>Smith, Jack</au><au>Tcheng, James E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)</atitle><jtitle>The American journal of cardiology</jtitle><date>2002</date><risdate>2002</risdate><volume>89</volume><issue>1</issue><spage>61</spage><epage>64</epage><pages>61-64</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial procedural costs by $151/patient ($4,423 vs $4,574, p=0.005) and costs related to ischemic complications by $61/patient ($283 vs $344, p=0.002).</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><doi>10.1016/S0002-9149(01)02165-8</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2002, Vol.89 (1), p.61-64
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_230368786
source ScienceDirect Freedom Collection 2022-2024
subjects Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Coronary vessels
Drug therapy
Hospital costs
Medical sciences
Pharmacology. Drug treatments
Stents
Transplants & implants
title In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A15%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In-hospital%20costs%20of%20coronary%20stent%20implantation%20with%20and%20without%20eptifibatide%20(the%20ESPRIT%20Trial)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Cohen,%20David%20J.&rft.date=2002&rft.volume=89&rft.issue=1&rft.spage=61&rft.epage=64&rft.pages=61-64&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/S0002-9149(01)02165-8&rft_dat=%3Cproquest_cross%3E99717538%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c364t-8e2ad0afd419fc50343858b6b454418e180dc28f7cb704d9e58b291e7df4e3413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230368786&rft_id=info:pmid/&rfr_iscdi=true